106 related articles for article (PubMed ID: 19167152)
1. Smooth-muscle-specific gene transfer with the human maxi-k channel improves erectile function and enhances sexual behavior in atherosclerotic cynomolgus monkeys.
Christ GJ; Andersson KE; Williams K; Zhao W; D'Agostino R; Kaplan J; Aboushwareb T; Yoo J; Calenda G; Davies KP; Sellers RS; Melman A
Eur Urol; 2009 Dec; 56(6):1055-66. PubMed ID: 19167152
[TBL] [Abstract][Full Text] [Related]
2. Editorial comment on: Smooth-muscle-specific gene transfer with the human maxi-K channel improves erectile function and enhances sexual behavior in atherosclerotic cynomolgus monkeys.
Hatzimouratidis K
Eur Urol; 2009 Dec; 56(6):1066. PubMed ID: 19167151
[No Abstract] [Full Text] [Related]
3. Gene transfer with a vector expressing Maxi-K from a smooth muscle-specific promoter restores erectile function in the aging rat.
Melman A; Biggs G; Davies K; Zhao W; Tar MT; Christ GJ
Gene Ther; 2008 Mar; 15(5):364-70. PubMed ID: 18200069
[TBL] [Abstract][Full Text] [Related]
4. Plasmid-based gene transfer for treatment of erectile dysfunction and overactive bladder: results of a phase I trial.
Melman A; Bar-Chama N; McCullough A; Davies K; Christ G
Isr Med Assoc J; 2007 Mar; 9(3):143-6. PubMed ID: 17402321
[TBL] [Abstract][Full Text] [Related]
5. Potassium channels and human corporeal smooth muscle cell tone: further evidence of the physiological relevance of the Maxi-K channel subtype to the regulation of human corporeal smooth muscle tone in vitro.
Spektor M; Rodriguez R; Rosenbaum RS; Wang HZ; Melman A; Christ GJ
J Urol; 2002 Jun; 167(6):2628-35. PubMed ID: 11992099
[TBL] [Abstract][Full Text] [Related]
6. 4-Aryl-3-(hydroxyalkyl)quinolin-2-ones: novel maxi-K channel opening relaxants of corporal smooth muscle targeted for erectile dysfunction.
Hewawasam P; Fan W; Ding M; Flint K; Cook D; Goggins GD; Myers RA; Gribkoff VK; Boissard CG; Dworetzky SI; Starrett JE; Lodge NJ
J Med Chem; 2003 Jul; 46(14):2819-22. PubMed ID: 12825925
[TBL] [Abstract][Full Text] [Related]
7. Gene transfer of the K(ATP) channel restores age-related erectile dysfunction in rats.
So I; Chae MR; Lee SW
BJU Int; 2007 Nov; 100(5):1154-60. PubMed ID: 17645416
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for male erectile dysfunction.
Melman A
Urol Clin North Am; 2007 Nov; 34(4):619-30, viii. PubMed ID: 17983901
[TBL] [Abstract][Full Text] [Related]
9. Molecular pathophysiology and gene therapy of aging-related erectile dysfunction.
Gonzalez-Cadavid NF; Rajfer J
Exp Gerontol; 2004; 39(11-12):1705-12. PubMed ID: 15582286
[TBL] [Abstract][Full Text] [Related]
10. 3-Thio-quinolinone maxi-K openers for the treatment of erectile dysfunction.
Boy KM; Guernon JM; Sit SY; Xie K; Hewawasam P; Boissard CG; Dworetzky SI; Natale J; Gribkoff VK; Lodge N; Starrett JE
Bioorg Med Chem Lett; 2004 Oct; 14(20):5089-93. PubMed ID: 15380205
[TBL] [Abstract][Full Text] [Related]
11. hMaxi-K gene transfer in males with erectile dysfunction: results of the first human trial.
Melman A; Bar-Chama N; McCullough A; Davies K; Christ G
Hum Gene Ther; 2006 Dec; 17(12):1165-76. PubMed ID: 17134370
[TBL] [Abstract][Full Text] [Related]
12. Frontiers in gene therapy for erectile dysfunction.
Christ GJ
Int J Impot Res; 2003 Oct; 15 Suppl 5():S33-40. PubMed ID: 14551575
[TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor (VEGF) gene therapy using a nonviral gene delivery system improves erectile function in a diabetic rat model.
Dall'Era JE; Meacham RB; Mills JN; Koul S; Carlsen SN; Myers JB; Koul HK
Int J Impot Res; 2008; 20(3):307-14. PubMed ID: 18273028
[TBL] [Abstract][Full Text] [Related]
14. Smooth muscle pathology and erectile dysfunction.
Wespes E
Int J Impot Res; 2002 Feb; 14 Suppl 1():S17-21. PubMed ID: 11850730
[TBL] [Abstract][Full Text] [Related]
15. [Advances in the research of penile erection and erection dysfunction].
Xin ZC; Lin GT; Zhang ZW; Guo YL
Sheng Li Ke Xue Jin Zhan; 2001 Apr; 32(2):129-34. PubMed ID: 12545882
[TBL] [Abstract][Full Text] [Related]
16. Intracavernosal vascular endothelial growth factor (VEGF) injection and adeno-associated virus-mediated VEGF gene therapy prevent and reverse venogenic erectile dysfunction in rats.
Rogers RS; Graziottin TM; Lin CS; Kan YW; Lue TF
Int J Impot Res; 2003 Feb; 15(1):26-37. PubMed ID: 12605238
[TBL] [Abstract][Full Text] [Related]
17. The first human trial for gene transfer therapy for the treatment of erectile dysfunction: preliminary results.
Melman A; Bar-Chama N; McCullough A; Davies K; Christ G
Eur Urol; 2005 Aug; 48(2):314-8. PubMed ID: 15964135
[TBL] [Abstract][Full Text] [Related]
18. K channels as molecular targets for the treatment of erectile dysfunction.
Christ GJ
J Androl; 2002; 23(5):S10-9. PubMed ID: 12236168
[No Abstract] [Full Text] [Related]
19. Superoxide dismutase - a target for gene therapeutic approach to reduce oxidative stress in erectile dysfunction.
Deng W; Bivalacqua TJ; Champion HC; Hellstrom WJ; Murthy SN; Kadowitz PJ
Methods Mol Biol; 2010; 610():213-27. PubMed ID: 20013181
[TBL] [Abstract][Full Text] [Related]
20. Ion channel gene therapy for smooth muscle disorders: relaxing smooth muscles to treat erectile dysfunction.
Schiff JD; Melman A
Assay Drug Dev Technol; 2006 Feb; 4(1):89-95. PubMed ID: 16506893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
